Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BELZER-MPS

K-Number: K972066 · 1997-11-26

Decision Date1997-11-26
Product CodeKDN
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

BELZER-MPS is the device name listed in this FDA 510(k) record. The listed applicant is Trans-Med Corp.. It received FDA 510(k) clearance on 1997-11-26 under 510(k) number K972066. The device is classified under product code KDN. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BELZER-MPS?

BELZER-MPS is a medical device that received FDA 510(k) clearance on 1997-11-26. The listed applicant is Trans-Med Corp.. The 510(k) number is K972066.

When did BELZER-MPS receive FDA 510(k) clearance?

BELZER-MPS received FDA 510(k) clearance on 1997-11-26, under 510(k) number K972066.

Who is the listed applicant for BELZER-MPS?

The FDA 510(k) record lists Trans-Med Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BELZER-MPS?

The FDA product code for BELZER-MPS is KDN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: KDN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑